In the U.S., FDA approval establishes Opdivo in combination with doxorubicin, vinblastine and dacarbazine (AVD) as the first immunotherapy combination approved for adult and pediatric patients 12 ...
In this series, we explore the impact of data from the National Genomic Research Library and highlight opportunities for ...
If these products had jobs, they'd all be up for employee of the year. View Entire Post › ...